Free Trial

Trillium, Analog Devices rise: General Motors, Lennar fall

Stocks that traded heavily or had substantial price changes Monday:

Pfizer Inc., up $1.21 to $49.93.

The Food and Drug Administration gave full approval to the COVID-19 vaccine the company developed with BioNTech.

Trillium Therapeutics Inc., up $11.50 to $17.59.

The developer of cancer treatments agreed to be acquired by Pfizer for more than $2 billion in cash.

DoorDash Inc., down $1 to $183.08.

A California judge struck down a ballot measure exempting app-based delivery and ride-hailing services from a law requiring drivers to be classified as employees.

General Motors Co., down 62 cents to $48.18.

The automaker is recalling all Chevrolet Bolt electric vehicles worldwide to fix a battery problem that could cause fires.

Madison Square Garden Entertainment Corp., up $10.12 to $72.55.

The company reported revenue that was higher than analysts were expecting as its venues resumed hosting live events.

Analog Devices Inc., up $2.99 to $169.63.

The chipmaker received antitrust clearance from Chinese regulators for its combination with Maxim Integrated Products.

Occidental Petroleum Corp., up $1.52 to $23.47.

Energy companies were broadly higher as crude oil prices regained some of the ground lost in recent days.

Lennar Corp., down 87 cents to $104.45.

Homebuilders were lower following a report that sales of previously occupied homes rose at a more moderate pace in July from a year ago.

Should You Invest $1,000 in Trillium Therapeutics Right Now?

Before you consider Trillium Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trillium Therapeutics wasn't on the list.

While Trillium Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
General Motors (GM)
4.0247 of 5 stars
$53.230.0%1.13%7.67Hold$55.17
Lennar (LEN)
4.6011 of 5 stars
$109.650.0%1.82%9.07Hold$128.85
Occidental Petroleum (OXY)
4.5298 of 5 stars
$43.630.2%2.20%17.74Hold$53.71
Pfizer (PFE)
4.9618 of 5 stars
$24.46-0.5%7.03%17.72Hold$28.55
Analog Devices (ADI)
4.5982 of 5 stars
$241.850.4%1.64%65.90Moderate Buy$258.89
Madison Square Garden Entertainment (MSGE)
2.0781 of 5 stars
$40.22-1.4%N/A14.68Buy$42.75
Trillium Therapeutics (TRIL)N/AC$0.00-100.0%N/A-34.06N/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines